Back to Results
First PageMeta Content
Pharmaceuticals policy / Pharmaceutical industry / Pharmacy / Drugs / Generic drug / Food and Drug Administration / Oxycodone / Rosiglitazone / Prescription medication / Pharmacology / Pharmaceutical sciences / Health


AprilPatent Monopolies and the Costs of Mismarketing Drugs By Ravi Katari and Dean Baker*
Add to Reading List

Document Date: 2015-04-27 16:52:50

Open Document

File Size: 444,22 KB

Share Result on Facebook

Company

Eli Lilly / the New York Times / Google / Purdue Pharmaceuticals / Pfizer / GlaxoSmithKline / Costco / Wilson / Merck / Zenios SA / CNN / Elite Pharmaceuticals Inc. / Walmart / /

Country

United States / /

Currency

USD / /

Event

Product Issues / FDA Phase / Product Recall / M&A / /

Facility

University of Washington / University of Pennsylvania / /

/

IndustryTerm

pharmaceutical industry / pharmaceutical / treatment of schizophrenia and bipolar disorder / pharmaceutical settlements / pharmaceuticals / pharmaceutical industry claims / chemicals / /

MedicalCondition

drug-induced heart disease / lifetime diabetes / II diabetes / drug-induced diabetes / riskproliferation syndrome / schizophrenia / sudden cardiac death / stroke / diabetes / pain / myocardial infarction / heart failure / serious heart disease / excess heart attacks / serious infection / bipolar disorder / /

Organization

University of Washington / United States Census Bureau / Food and Drug Administration / FDA’s office of Drug Safety / the University of Pennsylvania / Federal Trade Commission / Bureau of Economic Analysis / Graham et al. / Department of Justice / National Association of Chain Drug Stores / Centers for Disease Control and Prevention / Senate Finance Committee / Dean Baker* Center for Economic and Policy Research / Center for Economic and Policy Research in Washington / Wake Forest School of Medicine / American Heart Association / Center for Economic / /

Person

John Schmitt / Donald Light / Ravi Katari / Alan Barber / Van Zee / Kevin Cashman / Curt Furberg / Drugs By Ravi Katari / Nicole Woo / David Graham / Eileen Appelbaum / Dean Baker / /

/

Position

Professor Emeritus of Public Health Sciences / Dean / Co-director and an Economist / associate director / Contents Executive / /

Product

Bextra / olanzapine / Vioxx / PubMed / fentanyl / OxyContin / Avandia / rosiglitazone / Google Scholar / case / Zyprexa / size / COX-2 / approved / Chain drug / /

ProgrammingLanguage

DC / /

ProvinceOrState

Pennsylvania / /

PublishedMedium

The New York Times / /

TVStation

Koro / /

URL

http /

SocialTag